BCLI

Brainstorm Cell Therapeutics Inc.

$0.8430

+0.0000 (+0.00%)

Volume:

9.922K ($8.36K)

Market Capitalization:

Brainstorm Cell Therapeutics Price Chart

Brainstorm Cell Therapeutics Volume Chart

Brainstorm Cell Therapeutics Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.0154(+1.86%)

Open	$0.8276
Close	$0.8430
Low	$0.8276
Low Change	0.0000 (0.00%)
High	$0.9050
High Change	+0.0774 (+9.35%)
Range	$0.0774
Volume	9.922K
Dollar Volume	$8.36K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.0154(+1.86%)

Open	$0.8276
Close	$0.8430
Low	$0.8276
Low Change	0.0000 (0.00%)
High	$0.9050
High Change	+0.0774 (+9.35%)
Range	$0.0774
Volume	9.922K
Dollar Volume	$8.36K

Premarket Yesterday

*No Trades in Segment

Brainstorm Cell Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$0.8405
10 Day Moving Average (SMA10)	$0.7832
20 Day Moving Average (SMA20)	$0.7251
50 Day Moving Average (SMA50)	$0.6355
100 Day Moving Average (SMA100)	$0.6285
200 Day Moving Average (SMA200)	$0.7417

Brainstorm Cell Therapeutics Statistics

Average Volume (30 Days)	27.19K
P/E Ratio (Current)	-.72
EPS (Current)	-$1.16
Dividend Yield	0.00%
Free Cash Flow	-$9.49M
Cash Ratio	0.10
Current Ratio	0.18
Quick Ratio	0.18
Debt to Equity	-0.02
Enterprise Value	$7.44M
EV to EBITDA	-0.64
EV to Sales	—
Price to Book	-1.35
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	—
Return on Assets	-4.46%
Return on Equity	1.89%

Brainstorm Cell Therapeutics Stock Splits

There have been 2 stock splits for Brainstorm Cell Therapeutics (BCLI). The last reverse stock split occured on October 1, 2024 and reduced the outstanding shares at a ratio of 15:1.

Date	Type	Ratio
Oct 1, 2024	Reverse	15:1
Sep 16, 2014	Reverse	15:1

Brainstorm Cell Therapeutics Dividends

There have been no dividends for Brainstorm Cell Therapeutics (BCLI).